DrugPatentWatch Database Preview
Profile for Canada Patent: 2923102
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Canada Patent: 2923102
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Aug 12, 2028 | Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate |
Start Trial | Aug 12, 2028 | Inspirion Delivery | ROXYBOND | oxycodone hydrochloride |
Start Trial | Aug 12, 2028 | Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate |
Start Trial | Aug 12, 2028 | Inspirion Delivery | ROXYBOND | oxycodone hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |